Edesa Biotech, Inc.
EDSA
$7.69
$0.699.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 38.43% | 38.22% | -6.80% | 10.58% | -23.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.32% | 145.94% | -1.49% | -26.19% | 2.22% |
| Operating Income | -23.32% | -145.94% | 1.49% | 26.19% | -2.22% |
| Income Before Tax | -38.98% | -131.62% | -4.87% | 14.56% | 3.65% |
| Income Tax Expenses | -- | -- | -- | 0.00% | -- |
| Earnings from Continuing Operations | -38.98% | -131.62% | -4.87% | 14.55% | 3.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.98% | -131.62% | -4.87% | 14.55% | 3.65% |
| EBIT | -23.32% | -145.94% | 1.49% | 26.19% | -2.22% |
| EBITDA | -24.81% | -154.57% | 0.16% | 25.78% | -2.38% |
| EPS Basic | 41.70% | -6.65% | 51.89% | 48.58% | 9.90% |
| Normalized Basic EPS | 48.60% | -14.04% | 53.44% | 54.66% | 0.31% |
| EPS Diluted | 41.70% | -6.65% | 51.89% | 48.58% | 9.90% |
| Normalized Diluted EPS | 48.60% | -14.04% | 53.44% | 54.66% | 0.31% |
| Average Basic Shares Outstanding | 138.33% | 117.22% | 117.97% | 66.19% | 6.94% |
| Average Diluted Shares Outstanding | 138.33% | 117.22% | 117.97% | 66.19% | 6.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |